title: Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
authors.affiliation: Stanford University Medical Center, California.
authors.forename: M R
authors.initials: MR
authors.lastname: Kramer
authors.forename: S E
authors.initials: SE
authors.lastname: Marshall
authors.forename: D W
authors.initials: DW
authors.lastname: Denning
authors.forename: A M
authors.initials: AM
authors.lastname: Keogh
authors.forename: R M
authors.initials: RM
authors.lastname: Tucker
authors.forename: J N
authors.initials: JN
authors.lastname: Galgiani
authors.forename: N J
authors.initials: NJ
authors.lastname: Lewiston
authors.forename: D A
authors.initials: DA
authors.lastname: Stevens
authors.forename: J
authors.initials: J
authors.lastname: Theodore
mesh_terms: D001228:Aspergillosis / Q000188:drug therapy; D003048:Coccidiosis / Q000188:drug therapy; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced*; D016040:Lung Transplantation; D013174:Sporotrichosis / Q000188:drug therapy
chemical_list: D003524:Cyclosporins; D017964:Itraconazole; D007654:Ketoconazole